Healion Bio

Healion Bio is a biopharmaceutical company dedicated to developing treatments and preventive medicines for emerging infectious diseases. Healion's drug portfolio includes a class of broad-spectrum small-molecule oral antiviral drug candidates with a novel host-directed mechanism of action. Host-directed antivirals modulate human cells and tissues, differing from direct-acting antivirals that inhibit viral proteins and processes.